AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLDI
  4. [Form 4] Calidi Biotherapeutics, Inc. Insider Trading Activity

[Form 4] Calidi Biotherapeutics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source:

Stock CLDI logo
Calidi Biotherapeutics Inc

NYSE:CLDI

CLDI Rankings

#5876 Ranked by Market Cap
N/A Ranked by Dividends

CLDI Latest News

Aug 20, 2025
Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering
Aug 8, 2025
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
Jul 29, 2025
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma
Jul 25, 2025
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on聽August 5, 2025
Jul 22, 2025
Join Calidi Biotherapeutics鈥� Exclusive Live Investor Webinar and Q&A Session on July 24

CLDI Latest SEC Filings

Aug 15, 2025
[S-1] Calidi Biotherapeutics, Inc. Files IPO Registration Statement
Aug 14, 2025
[SCHEDULE 13G/A] Calidi Biotherapeutics, Inc. SEC Filing
Aug 14, 2025
[8-K] Calidi Biotherapeutics, Inc. Reports Material Event
Aug 8, 2025
[10-Q] Calidi Biotherapeutics, Inc. Quarterly Earnings Report
Aug 8, 2025
[8-K] Calidi Biotherapeutics, Inc. Reports Material Event

CLDI Stock Data

14.05M
2.72M
5.43%
8.5%
22.61%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SAN DIEGO